Metoprolol Dosing for Acute Tachycardia
Administer 5 mg of intravenous metoprolol over 1 to 2 minutes, and repeat every 5 minutes as needed up to a maximum total dose of 15 mg. 111111
Dosing Protocol
The standard approach for IV metoprolol in hemodynamically stable adults with sustained tachycardia >110 bpm is:
- Initial dose: 5 mg IV push over 1-2 minutes
- Repeat dosing: Additional 5 mg boluses every 5 minutes if needed
- Maximum total dose: 15 mg (three 5 mg doses)
This dosing regimen is consistently recommended across multiple American Heart Association ACLS guidelines 111111, the ACC/AHA/HRS SVT guidelines 2, the ACC/AHA/HRS atrial fibrillation guidelines 3, and FDA labeling 4.
Clinical Context
Beta-1 selective blockers like metoprolol are indicated for:
- Stable narrow-complex tachycardias uncontrolled by adenosine or vagal maneuvers
- Rate control in atrial fibrillation or atrial flutter
- Recurrent SVT 111
The 5 mg incremental dosing allows for titration based on response while monitoring for adverse effects. In clinical studies, mean doses of approximately 9.5 mg (range 2-15 mg) achieved rate control in 81% of patients with supraventricular tachyarrhythmias, reducing ventricular rate from 134 to 106 bpm within 10 minutes 5.
Monitoring Requirements
During administration, continuously monitor:
- Blood pressure (watch for hypotension <90 mmHg systolic)
- Heart rate (watch for excessive bradycardia <60 bpm)
- Electrocardiogram
- Hemodynamic stability 4
Hypotension occurred in approximately 10% of patients in clinical trials but was typically transient and manageable 56. The drug should be administered in a setting with intensive monitoring capabilities 4.
Contraindications to Verify
Do not administer if patient has:
- Decompensated heart failure
- Second- or third-degree heart block (without pacemaker)
- Severe bradycardia
- Reactive airway disease or severe COPD with bronchospasm
- Pre-excited atrial fibrillation/flutter (WPW syndrome) 1117
Comparative Efficacy
While diltiazem demonstrates superior rate control achievement compared to metoprolol (61% vs 44% achieving rate <110 bpm) 86, metoprolol remains an appropriate first-line agent, particularly when beta-blockade is specifically desired or calcium channel blockers are contraindicated. Both agents show similar safety profiles regarding hypotension and bradycardia 86.
The 5 mg incremental dosing strategy allows for individualized titration while maintaining safety, with most patients tolerating the full 15 mg dose (85% in large community practice studies) 9.